CEO & CFO Moves Review (October 11)

by | Oct 11, 2024

Weekly CEO & CFO Moves Update

This week saw notable executive leadership changes among U.S. public companies, particularly in the roles of CEO and CFO. Anterix Inc. announced the appointment of Scott Lang as CEO, succeeding Robert Harris Schwartz. Lang brings over 30 years of experience across telecommunications and utilities. Arts Way Manufacturing Co. also appointed Marc McConnell as CEO. McConnell previously served as the President of Bauer Corporation and has a background in diverse business operations.

Astec Industries and Benchmark Electronics made changes to their CFO positions. Brian Harris, formerly the EVP and CFO of Summit Materials, has joined Astec Industries as CFO, following Heinrich Jonker’s departure. At Benchmark Electronics, Bryan Schumaker has been appointed CFO, bringing extensive finance experience in technology and renewable energy sectors. Both transitions reflect ongoing adjustments to financial leadership across various industries.

Additional companies, including Black Diamond Therapeutics and Neurocrine Biosciences, made new appointments to their executive teams. Erika Jones joined Black Diamond Therapeutics as CFO, and Kyle Gano was appointed CEO of Neurocrine Biosciences. These leaders bring industry backgrounds that align with their respective companies’ focus areas in healthcare, technology, and finance. The series of appointments demonstrates a continuation of executive transitions as companies adapt to evolving business needs.

This Week’s CEO and CFO Moves

COMPANY FLAGS ROLE LEAVING JOINING JOINER BIOGRAPHY
ANTERIX INC 

Ticker: ATEX
Mkt Cap: $595.4M
1-Yr TSR: 1.0%

  • 13D filed in the last 6 months
  • Amended Filing (10-K/A)
  • Amended Filing (10-Q/A)
  • Director Elections: < 95% average votes FOR
  • Gov Risk: Chairman is not independent
  • Gov Risk: Entrenched Board
  • Gov Risk: More than one Director over 75
  • Immediate Resignation
  • Internal Control Risk
  • Late Filings (NT 10-K / NT 10-Q)
CEO Robert Harris Schwartz
4.3 yrs
-7.3% TSR
Scott A Lang Lang is a highly accomplished and seasoned global executive with a demonstrated history of innovation, having spent more than 30 years working with major companies at the intersection of telecommunications and electric utilities. As the former CEO and Executive Chairman for Silver Spring Networks, Inc., Lang played a major role in successfully positioning the company as an innovative leader within…read full bio
ARTS WAY MANUFACTURING CO INC 

Ticker: ARTW
Mkt Cap: $8.7M
1-Yr TSR: -29.3%

  • Amended Filing (10-K/A)
  • Amended Filing (10-Q/A)
  • CEO Tenure Was Under 2 Years: Michael B Hilderbrand
  • CFO Tenure Was Under 2 Years: Carrie Gunnerson
  • CFO Tenure Was Under 2 Years: Jason D Feucht
  • Director Elections: < 95% average votes FOR
  • Executive Termination
  • Executive Termination(s) within the last year
  • Gov Risk: Average Director tenure over 10 years
  • Gov Risk: Entrenched Board
CEO David Alan King
4.3 yrs
-6.3% TSR
Marc H McConnell Mr. McConnell is currently the President of Bauer Corporation and McConnell Holdings, Inc. Mr. McConnell previously served as the Chairman of the Board, Chairman of the Audit Committee, Chairman of the Executive Committee of Integrated Financial Holdings, Inc., a financial holding company headquartered in Raleigh, North Carolina. Mr. McConnell had served as a director of Integrated Financial Holdi…read full bio
ASTEC INDUSTRIES INC 

Ticker: ASTE
Mkt Cap: $696.3M
1-Yr TSR: -32.8%

  • 13D filed in the last 6 months
  • Amended Filing (10-Q/A)
  • CEO Tenure Was Under 2 Years: Richard J Dorris
  • CFO Tenure Was Under 2 Years: Heinrich Jonker
  • Class Action
  • Deceased Person Disclosure
  • Director Elections: < 95% average votes FOR
  • Executive Termination
  • Gov Risk: Classified Board / Staggered Director Elections
  • Gov Risk: More than one Director over 75
CFO Heinrich Jonker
.6 yrs *interim*
-11.7% TSR
Brian James Harris Mr. Harris, age 68, served as Executive Vice President and Chief Financial Officer of Summit Materials, Inc. (“Summit”), a leading producer of aggregates and cement, from October 2013 to February 2023. Prior to his role at Summit, Mr. Harris served as Executive Vice President and Chief Financial Officer of Bausch + Lomb Corporation, an eye health products company, from 2009 to 2013. Prior to joini…read full bio
BENCHMARK ELECTRONICS INC 

Ticker: BHE
Mkt Cap: $1.6B
1-Yr TSR: 78.9%

  • Amended Filing (10-K/A)
  • Amended Filing (10-Q/A)
  • CFO Tenure Was Under 2 Years: Arvind Kamal
  • Contested Proxy (BHE)
  • Cooperation Agreement
  • Cyber Incident
  • Executive Termination
  • Guidance Withdrawn/Suspended
  • Ind. Accountant Resigned
  • Material Stock Drop(s) in past 2 years
CFO Arvind Kamal
.5 yrs *interim*
46.0% TSR
Bryan Robert Schumaker Most recently Mr. Schumaker served as EVP and CFO of SOURCE Global, PBC, who produces the world’s first fully renewable drinking water system. Prior to that assignment Mr. Schumaker held CFO roles at TPI Composites, Inc. (NASDAQ:TPIC) and 8point3 Energy Partners (NASDAQ:CAFD), while previously serving as Senior Vice President and Chief Accounting Officer for First Solar, Inc. (NASDAQ:FSLR)….read full bio
BLACK DIAMOND THERAPEUTICS INC 

Ticker: BDTX
Mkt Cap: $194.4M
1-Yr TSR: 26.0%

  • 13D filed in the last 6 months
  • Director Elections: < 95% average votes FOR
  • Gov Risk: Chairman is not independent
  • Gov Risk: Classified Board / Staggered Director Elections
  • Immediate Resignation
  • Material Stock Drop(s) in past 2 years
  • overboarding
  • Significant Stock Drop: -16.4% net one-day
  • Significant Stock Drop: -21.8% net one-day
  • Significant Stock Drop: -37.3% net one-day
CFO Fang Ni
2.9 yrs *interim*
-17.4% TSR
Erika Jones Erika Jones has served as our Senior Vice President, Finance since February 2024 and as Corporate Controller since January 2021. Ms. Jones previously served as Vice President, Finance from October 2021 until her promotion in February 2024. Ms. Jones joined the Company in 2019 and served as Senior Director, Finance from October 2019 to January 2021. Prior to joining us, from May 2016 to October 201…read full bio
CERENCE INC 

Ticker: CRNC
Mkt Cap: $136.3M
1-Yr TSR: -82.0%

  • CFO Tenure Was Under 2 Years: Daniel David Tempesta
  • CFO Tenure Was Under 2 Years: Marc Montagner
  • CFO Tenure Was Under 2 Years: Stefan Ortmanns
  • CFO Tenure Was Under 2 Years: Thomas L Beaudoin
  • Class Action
  • Director Elections: < 95% average votes FOR
  • Guidance Withdrawn(s) in the last year
  • Guidance Withdrawn/Suspended
  • High Activist Vulnerability Risk Score (95)
  • High CFO Turnover
CEO Stefan Ortmanns
2.8 yrs
-70.3% TSR
Brian M Krzanich Mr. Krzanich, 64, most recently served as Chief Executive Officer of CDK Global, an automotive software company, from 2018 to 2022. Prior to that, Mr. Krzanich served in a number of roles at Intel Corporation beginning in 1982, leading to his ascension to the role of Chief Executive Officer of Intel Corporation from 2013 to 2018. Under his leadership, Intel expanded from its core CPU mar…read full bio
COHERENT CORP 

Ticker: COHR
Mkt Cap: $15.2B
1-Yr TSR: 199.5%

  • Amended Filing (10-K/A)
  • Amended Filing (10-Q/A)
  • Class Action
  • Director Elections: < 95% average votes FOR
  • Executive Termination
  • Gov Risk: Chairman is not independent
  • Immediate Resignation
  • Material Stock Drop(s) in past 2 years
  • Merger Agreement
  • Settlement Agreement
CFO Richard Martucci
1.1 yrs *interim*
Sherri R Luther Ms. Luther, age 59, has served as the chief financial officer of Lattice Semiconductor Corporation (“Lattice”) since January 2019. Prior to joining Lattice, Ms. Luther was a senior financial executive at Coherent, Inc. for over sixteen years, and most recently served as its Corporate Vice President of Finance. Prior to joining Coherent, Inc., Ms. Luther held a number of…read full bio
EASTSIDE DISTILLING INC 

Ticker: EAST
Mkt Cap: $1.0M
1-Yr TSR: -72.1%

  • Amended Filing (10-K/A)
  • Amended Filing (10-Q/A)
  • Amended Filings (10-K/A) within the last year
  • CEO Tenure Was Under 2 Years: Lawrence Firestone
  • CEO Tenure Was Under 2 Years: Paul Block
  • CEO Tenure Was Under 2 Years: Steve Shum
  • CFO Tenure Was Under 2 Years: Steven Earles
  • Director Elections: < 95% average votes FOR
  • Going Concern Risk Filings in the last year
  • High Activist Vulnerability Risk Score (77)
CFO Geoffrey C Gwin
4.3 yrs
-60.8% TSR
Christopher R Moe Christopher R. Moe, Chief Financial Officer. Since 2023 Mr. Moe has served as the Chief Financial Officer of Beeline Financial Holdings, Inc. an AI assisted all digital home loan lending and title platform designed to simplify the process of home financing. From 2018 until 2023, he was the Chief Financial Officer and a Director of Yates Electrospace Corporation, a heavy payload contested…read full bio
EMPLOYERS HOLDINGS INC 

Ticker: EIG
Mkt Cap: $1.2B
1-Yr TSR: 23.6%

  • Amended Filing (10-K/A)
  • Director Elections: < 95% average votes FOR
  • Executive Termination
  • Internal Investigation
  • Late Filings (NT 10-K / NT 10-Q)
  • Limited external board experience
  • Material Stock Drop(s) in past 2 years
  • Merger Agreement
  • Rule 10b5-1 Entered
  • Significant Stock Drop: -15.4% net one-day
CFO Michael Scott Paquette
8.2 yrs
6.3% TSR
Michael A. Pedraja Mr. Pedraja, age 56, has served as Group Chief Financial Officer for Ariel Re Services, a global reinsurance underwriter and service provider, since May 2021. From April 2019 to April 2021, Mr. Pedraja served as Senior Vice President and Treasurer of The Allstate Corporation (NYSE:ALL). Prior to joining The Allstate Corporation, Mr. Pedraja worked as an investment banker for over 20 years focusing…read full bio
GENESCO INC 

Ticker: GCO
Mkt Cap: $296.5M
1-Yr TSR: -12.5%

  • Amended Filing (10-K/A)
  • Amended Filing (10-Q/A)
  • CFO Tenure Was Under 2 Years: Melvin G Tucker
  • CFO Tenure Was Under 2 Years: Mimi Eckel Vaughn
  • Contested Proxy (GCO)
  • Cooperation Agreement
  • Director Elections: < 95% average votes FOR
  • Guidance Withdrawn/Suspended
  • High CFO Turnover
  • Material Stock Drop(s) in past 2 years
CFO Thomas George
3.8 yrs
1.1% TSR
Sandra Harris Prior to joining the Company, Ms. Harris, age 52, served as Chief Financial Officer of Artisan Design Group, LLC from February 2023 to April 2024. Previously, Ms. Harris served as Tupperware Brands Corp.’s (“Tupperware”) (i) Chief Financial Officer and Chief Operating Officer from October 2020 to June 2022 and (ii) Executive Vice President and Chief Financial Officer from April 2…read full bio
GOHEALTH INC 

Ticker: GOCO
Mkt Cap: $217.2M
1-Yr TSR: -33.1%

  • CFO Tenure Was Under 2 Years: Jason Schulz
  • CFO Tenure Was Under 2 Years: Katherine O’Halloran
  • CFO Tenure Was Under 2 Years: Travis J Matthiesen
  • CFO Tenure Was Under 2 Years: Vance Cushman Johnston
  • Class Action
  • Director Elections: < 95% average votes FOR
  • Gov Risk: Chairman is not independent
  • Guidance Withdrawn/Suspended
  • High Activist Vulnerability Risk Score (82)
  • High CFO Turnover
CFO Katherine O’Halloran
.3 yrs
Brendan Shanahan Mr. Shanahan, age 62, has over 30 years of financial leadership experience and over 20 years of expertise in the Medicare Advantage industry. Prior to joining the Company as Chief Financial Officer, Mr. Shanahan served from March 2022 to February 2024 as Chief Financial Officer of UpStream Care Company, a primary care services and technology company, and from July 2015 to June 2021 as Executive Vi…read full bio
INTREPID POTASH INC 

Ticker: IPI
Mkt Cap: $314.8M
1-Yr TSR: 3.1%

  • Amended Filing (10-K/A)
  • Amended Filing (10-Q/A)
  • Amended Filings (10-K/A) within the last year
  • Bankruptcy Alert: 2 directors have bankruptcy histories (IPI)
  • Director Elections: < 95% average votes FOR
  • Executive Termination
  • Gov Risk: Chairman is not independent
  • Gov Risk: Classified Board / Staggered Director Elections
  • High Activist Vulnerability Risk Score (93)
  • Listing Rule Violation: Average Closing Price
CEO Robert P Jornayvaz III
10.1 yrs
-16.6% TSR
TBD TBD
LATTICE SEMICONDUCTOR CORP 

Ticker: LSCC
Mkt Cap: $7.1B
1-Yr TSR: -37.5%

  • Amended Filing (10-K/A)
  • Amended Filing (10-Q/A)
  • CEO Tenure Was Under 2 Years: Christopher M Fanning
  • CEO Tenure Was Under 2 Years: Esam Elashmawi
  • CEO Tenure Was Under 2 Years: Glen Hawk
  • CFO Tenure Was Under 2 Years: Maxwell J Downing
  • Director Elections: < 95% average votes FOR
  • Immediate Resignation
  • Late Filings (NT 10-K / NT 10-Q)
  • Material Stock Drop(s) in past 2 years
CFO Sherri R Luther
5.8 yrs
Tonya Steven Ms. Stevens, age 52, joined the Company in May 2019 as its Vice President and Corporate Controller. While at Lattice, Ms. Stevens has led key strategic transformations that helped the company optimize its operations and strengthen its financial foundation. Prior to joining the Company, Ms. Stevens held finance leadership roles at a variety of companies, including Intel Corp. and Price Waterhouse C…read full bio
NEUROCRINE BIOSCIENCES INC 

Ticker: NBIX
Mkt Cap: $11.4B
1-Yr TSR: -1.6%

  • Amended Filing (10-K/A)
  • CFO Tenure Was Under 2 Years: David-Alexandre C Gros
  • Director Elections: < 95% average votes FOR
  • Gov Risk: Average Director tenure over 10 years
  • Gov Risk: Classified Board / Staggered Director Elections
  • Gov Risk: Entrenched Board
  • Immediate Resignation
  • Material Stock Drop(s) in past 2 years
  • Significant Stock Drop: -18.1% net one-day
  • Significant Stock Drop: -18.9% net one-day
CEO Kevin Charles Gorman
16.8 yrs
17.5% TSR
Kyle Gano Dr. Gano was appointed Neurocrine’s Chief Business Development Officer in 2011, and Chief Business Development and Strategy Officer in 2020, and is responsible for all of Neurocrine’s business and corporate development activities, including the management of ongoing collaborations with AbbVie, Mitsubishi Tanabe Pharma, Sentia Medical Sciences, Jnana Therapeutics, Voyager Therapeut…read full bio
NRX PHARMACEUTICALS INC 

Ticker: NRXP
Mkt Cap: $15.0M
1-Yr TSR: -49.6%

  • Abnormally High 8-K Filings
  • Amended Filing (10-K/A)
  • Amended Filing (10-Q/A)
  • CEO Tenure Was Under 2 Years: Jonathan C Javitt
  • CEO Tenure Was Under 2 Years: Robert Besthof
  • CFO Tenure Was Under 2 Years: Ira S Strassberg
  • CFO Tenure Was Under 2 Years: Seth Van Voorhees
  • CFO Tenure Was Under 2 Years: William Fricker
  • Class Action
  • Director Elections: < 95% average votes FOR
CEO Stephen H Willard
2.3 yrs
Jonathan C Javitt Jonathan Javitt, M.D., M.P.H. Dr. Javitt, founder of the Company, serves as our Chairman and as Chief Scientist and was re-elected Chairman in December 2023. Dr. Javitt additionally served as the Company’s CEO from May 2021 until March 2022. He was the Co-founder, Chairman, and CEO of NeuroRx, Inc., which merged with the Company in May 2021. He participated in leading drug and medical device devel…read full bio
NUVATION BIO INC 

Ticker: NUVB
Mkt Cap: $501.0M
1-Yr TSR: 66.1%

  • 13D filed in the last 6 months
  • Amended Filing (10-K/A)
  • Bankruptcy Alert: 1 director has a bankruptcy history (NUVB)
  • CFO Tenure Was Under 2 Years: Moses Makunje
  • Director Elections: < 95% average votes FOR
  • Gov Risk: Classified Board / Staggered Director Elections
  • High CFO Turnover
  • Immediate Resignation
  • Internal Control Risk
  • Material Stock Drop(s) in past 2 years
CFO Moses Makunje
.9 yrs
121.0% TSR
Philippe Sauvage Prior to joining the Company, Mr. Sauvage, 47 years old, served as Senior Vice President, Global Head of Operations and Access for Sanofi from 2020 to 2024. Mr. Sauvage also served Sanofi as Head of Commercial Strategy and Portfolio Marketing – DUPIXENT from 2019-2020, Chief Financial Officer for Sanofi-Genzyme and Sanofi North America from 2015-2019, and Chief Financial…read full bio
OPTINOSE INC 

Ticker: OPTN
Mkt Cap: $98.0M
1-Yr TSR: -47.2%

  • CFO Tenure Was Under 2 Years: Anthony J Krick
  • CFO Tenure Was Under 2 Years: Michele Janis
  • CFO Tenure Was Under 2 Years: Peter K Miller
  • Director Elections: < 95% average votes FOR
  • Executive Termination
  • Going Concern Risk Filings in the last year
  • Gov Risk: Classified Board / Staggered Director Elections
  • High CFO Turnover
  • Material Stock Drop(s) in past 2 years
  • Significant Stock Drop: -15.1% net one-day
CFO Anthony J Krick
1.8 yrs *interim*
-37.1% TSR
Terry Kohler Mr. Kohler, age 47, is an experienced biotech finance leader with over 20 years of business experience. He was most recently the Chief Financial Officer for Verrica Pharmaceuticals, a publicly-held dermatology therapeutics company, from July 2021 to October 2024, where he supported commercial preparations for the launch of a topical treatment for molluscum contagiosum and research and development…read full bio
REALPHA TECH CORP 

Ticker: AIRE
Mkt Cap: $53.6M
1-Yr TSR: %

  • CFO Tenure Was Under 2 Years: Michael Frenz
  • CFO Tenure Was Under 2 Years: Michael J Logozzo
  • Executive Termination
  • Executive Termination(s) within the last year
  • Going Concern Risk Filings in the last year
  • High CFO Turnover
  • Late Filings (NT 10-K / NT 10-Q)
  • Late Filings (NT 10-K / NT 10-Q) within the last year
  • Material Stock Drop(s) in past 2 years
  • SEC Correspondence in the last year
CFO William B Miller
.2 yrs
Rakesh Prasad Mr. Prasad, age 35, has over 10 years of finance reporting and audit experience. Mr. Prasad has been with the Company since May 2021 as a Director of reAlpha Techcorp Private Limited, one of the Company’s subsidiaries, as a Finance Controller from such date until January 2022 and as the Vice President of Finance since February 2022, where he directs the preparation and consolidation of the C…read full bio
TURNSTONE BIOLOGICS CORP 

Ticker: TSBX
Mkt Cap: $10.5M
1-Yr TSR: -86.9%

  • Going Concern Risk Filings in the last year
  • Listing Rule Violation: Minimum Bid
  • Material Stock Drop(s) in past 2 years
  • Significant Stock Drop: -15.4% net one-day
  • Significant Stock Drop: -16.8% net one-day
  • Significant Stock Drop: -17.0% net one-day
  • Significant Stock Drop: -17.9% net one-day
  • Significant Stock Drop: -18.9% net one-day
  • Significant Stock Drop: -21.2% net one-day
  • Significant Stock Drop: -30.7% net one-day
CFO Venkat Ramanan
2.7 yrs
Wendy Worcester  From July 2018 to April 2020, from Ms. Worcester served as the Chief Financial Officer of Gateway Genomics, LLC, a biotechnology company developing fetal and infant DNA technology. Since 2007, Ms. Worcester has served as the Managing Director of WJW Consulting, a fractional and advisory chief financial officer services company. Ms. Worcester received a B.S. in Business with an…read full bio
UNITED PARKS & RESORTS INC 

Ticker: PRKS
Mkt Cap: $2.9B
1-Yr TSR: 8.3%

  • 13D filed in the last 6 months
  • Amended Filing (10-K/A)
  • CEO Tenure Was Under 2 Years: Alessandro David F D
  • CEO Tenure Was Under 2 Years: Gustavo Antorcha
  • CEO Tenure Was Under 2 Years: John T Reilly
  • CEO Tenure Was Under 2 Years: Sergio Rivera
  • CFO Tenure Was Under 2 Years: James (“Jim”) W. Forrester, Jr.,
  • CFO Tenure Was Under 2 Years: Michelle (“Chelle”) Adams
  • CFO Tenure Was Under 2 Years: Peter J Crage
  • Cooperation Agreement
CFO James (“Jim”) W. Forrester, Jr.,
1.8 yrs *interim*
-3.4% TSR
James Mikolaichik Prior to becoming the Company’s Chief Financial Officer, Mr. Mikolaichik, 53, served as the Chief Financial Officer of MyEyeDr., an eye health and wellness company, from December 2022 until October 2024. Prior to MyEyeDr., Mr. Mikolaichik served as the Chief Financial Officer of Diamond Resorts, a hospitality, vacation ownership and entertainment company, from September 2018 until August 202…read full bio
UNIVERSAL TECHNICAL INSTITUTE INC 

Ticker: UTI
Mkt Cap: $832.5M
1-Yr TSR: 83.3%

  • Amended Filing (10-Q/A)
  • CFO Tenure Was Under 2 Years: Bryce H Peterson
  • CFO Tenure Was Under 2 Years: Scott Yessner
  • Director Elections: < 95% average votes FOR
  • Gov Risk: Classified Board / Staggered Director Elections
  • Guidance Withdrawn/Suspended
  • Internal Control Risk
  • Limited external board experience
  • Material Stock Drop(s) in past 2 years
  • Negative Say-On-Pay Vote: 89% For
CFO Troy R Anderson
5.1 yrs
28.6% TSR
Christine Kline
(interim)
Ms. Kline, age 46, has served as the Company’s Vice President and Chief Accounting Officer since December 2023. Prior to this role, she served as Vice President, Corporate Controller since joining the Company in February 2020. Prior to joining the Company, Ms. Kline served as the Director of Financial Reporting at Nuverra Environmental Solutions from July 2015 to February 2020 and…read full bio
UROGEN PHARMA LTD 

Ticker: URGN
Mkt Cap: $501.6M
1-Yr TSR: -13.4%

  • Amended Filing (10-K/A)
  • Amended Filings (10-K/A) within the last year
  • CFO Tenure Was Under 2 Years: Molly Henderson
  • Director Elections: < 95% average votes FOR
  • Failed Say-On-Pay Vote: 42% For
  • Failed Say-On-Pay Vote: 44% For
  • High CFO Turnover
  • Immediate Resignation
  • Material Stock Drop(s) in past 2 years
  • Negative Say-On-Pay Vote: 77% For
CFO Dong (Don) Kim
2.6 yrs
26.1% TSR
Christopher William Degnan Prior to joining the Company, Christopher Degnan, age 45, served as the Chief Financial Officer of Galera Therapeutics, Inc., a publicly traded biopharmaceutical company focused on oncology, from October 2019 to August 2024. Prior to Galera, Mr. Degnan served as the Chief Financial Officer of Verrica Pharmaceuticals Inc., a publicly traded biotechnology company focused on medical dermatology,…read full bio
VIRPAX PHARMACEUTICALS INC 

Ticker: VRPX
Mkt Cap: $2.2M
1-Yr TSR: -94.0%

  • Abnormally High 8-K Filings
  • Amended Filing (10-K/A)
  • CEO Tenure Was Under 2 Years: Gerald W Bruce
  • CFO Tenure Was Under 2 Years: Vinay Shah
  • Director Elections: < 95% average votes FOR
  • Failed to File Annual/Quarterly Report
  • Going Concern Risk Filings in the last year
  • High Activist Vulnerability Risk Score (99)
  • Immediate Resignation
  • Ind. Accountant Resigned
CEO Gerald W Bruce
.9 yrs
-91.2% TSR
Jatinder Dhaliwal Jatinder (Jay) Dhaliwal is a registered pharmacist and has served as CEO and director of multiple publicly traded companies listed in Canadian (CSE, TSX) and American (Nasdaq) exchanges. Since June 2022, Mr. Dhaliwal has served as director and chairman of the board of Akanda Corp., a leading seed to patient cannabis producer based out of Europe and currently listed on the Nasdaq. He also serv…read full bio
VIRPAX PHARMACEUTICALS INC 

Ticker: VRPX
Mkt Cap: $2.2M
1-Yr TSR: -94.0%

  • Abnormally High 8-K Filings
  • Amended Filing (10-K/A)
  • CEO Tenure Was Under 2 Years: Gerald W Bruce
  • CFO Tenure Was Under 2 Years: Vinay Shah
  • Director Elections: < 95% average votes FOR
  • Failed to File Annual/Quarterly Report
  • Going Concern Risk Filings in the last year
  • High Activist Vulnerability Risk Score (99)
  • Immediate Resignation
  • Ind. Accountant Resigned
CFO Vinay Shah
1.3 yrs
-82.1% TSR
TBD TBD
WORTHINGTON ENTERPRISES INC 

Ticker: WOR
Mkt Cap: $2.0B
1-Yr TSR: 4.5%

  • Abnormally High 8-K Filings
  • Amended Filing (10-K/A)
  • Director Elections: < 95% average votes FOR
  • Gov Risk: Chairman is not independent
  • Gov Risk: Classified Board / Staggered Director Elections
  • Gov Risk: Entrenched Board
  • Gov Risk: More than one Director over 75
  • Ind. Accountant Resigned
  • Late Filings (NT 10-K / NT 10-Q)
  • Material Stock Drop(s) in past 2 years
CEO B Andrew Rose
4.1 yrs
14.9% TSR
Joseph B Hayek Mr. Hayek (age 52) currently serves as the Company’s Executive Vice President and Chief Financial and Operations Officer, and has served in such role since December 2023. Mr. Hayek previously served as the Company’s Vice President and Chief Financial Officer from November 2018 to November 2023. Mr. Hayek served as Vice President and General Manager of the Company’s oil and gas equipment business u…read full bio
WORTHINGTON ENTERPRISES INC 

Ticker: WOR
Mkt Cap: $2.0B
1-Yr TSR: 4.5%

  • Abnormally High 8-K Filings
  • Amended Filing (10-K/A)
  • Director Elections: < 95% average votes FOR
  • Gov Risk: Chairman is not independent
  • Gov Risk: Classified Board / Staggered Director Elections
  • Gov Risk: Entrenched Board
  • Gov Risk: More than one Director over 75
  • Ind. Accountant Resigned
  • Late Filings (NT 10-K / NT 10-Q)
  • Material Stock Drop(s) in past 2 years
CFO Joseph B Hayek
5.9 yrs
11.0% TSR
Colin J. Souza Mr. Souza (age 36) currently serves as the Company’s Vice President of Finance, and has served in such role since December 2023. Mr. Souza previously served as the Company’s Director of Corporate Development and Mergers & Acquisitions from January 2021 to December 2023, and as Manager of Corporate Development and Mergers & Acquisitions from July 2019 to December 2021. Prior to…read full bio

 

Recent Analysis

CEO & CFO Moves Review – November 8, 2024

Explore last week’s CEO and CFO transitions at major public companies like Adial Pharmaceuticals, Affirm Holdings, Agrify Corp, and Dollar Tree. Learn about the new leaders taking charge amidst financial challenges, governance risks, and stock performance issues. This update covers executive shifts at companies facing shareholder pressures, regulatory scrutiny, and strategic reorganizations.

Daily SPAC Update – November 7, 2024

ACAB + Abpro SPAC Deal Vote. MCAA Extension Vote. FRLA and INTE Shareholders Extend. ROCL Deal and GLAC Extension Votes Set. ACAB Non-Redemption Agreement.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.